COVID-19 Vaccine Timeline Expectations Have Become Unrealistic, Warns Porges
Herd Immunity Goal Could Be Years Away
Executive Summary
Despite record-breaking speed bringing several vaccine candidates into Phase I trials, the road ahead is likely to be much more treacherous and slow, warns one analyst.
You may also be interested in...
India's Serum Joins Oxford Efforts To Expedite COVID-19 Vaccine
After partnering with Merck KGaA and Cobra Biologics, Oxford University has now tied up with Serum Institute of India to manufacture its COVID-19 vaccine and a marketing pact is likely. With clinical trials of the ChAdOx1 nCoV-19 vaccine underway, Serum intends to set aside other COVID-19 vaccine development plans for the time being.
Novartis’s ‘Poster Child’ Zolgensma Shows What Gene Therapy Can Do – And Its Limitations
The clinical development head of Novartis Gene Therapies talks about the progress for SMA patients more than seven years after treatment began, and hopes of boosting outcomes by treating pre-symptomatic patients.
Former Seagen CEO Siegall Takes Helm At New Biotech Morphimmune
Siegall is moving on after an unhappy exit from Seagen with a new role at another company with a novel targeted oncology platform.